Secondary Neoplasia (Other Than PTLPS)
Options
BORIS DOI
Date of Publication
2024
Publication Type
Book Section
Division/Institute
Editor
Sureda, Anna | |
Corbacioglu, Selim | |
Greco, Raffaella | |
Kröger, Nicolaus | |
Carreras, Enric |
Subject(s)
Publisher
Springer International Publishing
Language
English
Publisher DOI
PubMed ID
39437034
Description
Secondary Neoplasia (SN) after HCT belong to the most feared long-term complications. They include any malignant disorder occurring after HCT. There are three types of SN: therapy-related myeloid neoplasms, occurring mainly after auto-HCT; donor-derived malignancies after allo-HCT; and second solid neoplasms after either auto- or allo-HCT. Many of these SN have a higher incidence compared to the general population. In this chapter, pathophysiology issues, risk factors, screening and management recommendations are discussed. Since SN can occur even decades after HCT, life-long surveillance is needed.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| 978-3-031-44080-9_47.pdf | text | Adobe PDF | 417.48 KB | Attribution (CC BY 4.0) | published |